Influx Healthtech Limited (NSE:INFLUX)
246.20
-3.95 (-1.58%)
At close: Jun 1, 2026
Influx Healthtech Revenue
In the fiscal year ending March 31, 2026, Influx Healthtech had annual revenue of 1.47B INR with 40.04% growth. Influx Healthtech had revenue of 400.35M in the quarter ending March 31, 2026, with 48.61% growth.
Revenue
1.47B
Revenue Growth
+40.04%
P/S Ratio
3.94
Revenue / Employee
n/a
Employees
163
Market Cap
5.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.47B | 419.80M | 40.04% |
| Mar 31, 2025 | 1.05B | 48.89M | 4.89% |
| Mar 31, 2024 | 999.65M | 239.09M | 31.44% |
| Mar 31, 2023 | 760.57M | 168.55M | 28.47% |
| Mar 31, 2022 | 592.02M | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bajaj HealthCare | 6.11B |
| NGL Fine-Chem | 5.01B |
| Aarey Drugs & Pharmaceuticals | 4.78B |
| Sai Parenteral's | 3.81B |
| Anlon Healthcare | 1.72B |
| Kimia Biosciences | 1.17B |
| Panchsheel Organics | 1.10B |
| Shree Ganesh Remedies | 1.09B |